Vascular endothelial function is impaired by aerosol from a single IQOS HeatStick to the same extent as by cigarette smoke

Tobacco Control

Volumn 27, Issue , 2018, Pages s13-s19

  Nabavizadeh, Pooneh ^a   Liu, Jiangtao ^a   Havel, Christopher M ^a   Ibrahim, Sharina ^a   Derakhshandeh, Ronak ^a   Jacob, Peyton ^a,b   Springer, Matthew L ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

electronic nicotine delivery devices; harm reduction; nicotine; non cigarette tobacco products; smoking caused disease

Indexed keywords

COTININE; NICOTINE;

AEROSOL; ANIMAL; ARTERY; BLOOD; CHEMISTRY; COMPARATIVE STUDY; MALE; PATHOPHYSIOLOGY; PHYSIOLOGY; RAT; SMOKE; TOBACCO; VASODILATATION;

AEROSOLS; ANIMALS; ARTERIES; COTININE; MALE; NICOTINE; RATS; SMOKE; TOBACCO; TOBACCO PRODUCTS; VASODILATION;

EID: 85053121827     PISSN: 09644563     EISSN: 14683318     Source Type: Journal    
DOI: 10.1136/tobaccocontrol-2018-054325     Document Type: Article

References (53)

1. Philip Morris International. Designing a smoke-free future. https://www. pmi. com (accessed 24 Jan 2018).
2. U. S. Food and Drug Administration. Philip Morris products S. A. Modified Risk Tobacco Product (MRTP) Applications. https://www. fda. gov/ TobaccoProducts/ Labeling/ Mark etin gand Adve rtising/ ucm546281. htm
3. Schorp MK, Tricker AR, Dempsey R. Reduced exposure evaluation of an electrically heated cigarette smoking system. Part 1: Non-clinical and clinical insights. Regul Toxicol Pharmacol 2012;64(Suppl):S1-10.
4. Zenzen V, Diekmann J, Gerstenberg B, et al. Reduced exposure evaluation of an Electrically Heated Cigarette Smoking System. Part 2: Smoke chemistry and in vitro toxicological evaluation using smoking regimens reflecting human puffing behavior. Regul Toxicol Pharmacol 2012;64(Suppl):S11-34.
5. Tricker AR, Stewart AJ, Leroy CM, et al. Reduced exposure evaluation of an electrically heated cigarette smoking system. Part 3: Eight-day randomized clinical trial in the UK. Regul Toxicol Pharmacol 2012;64(Suppl):S35-44.
6. Tricker AR, Jang IJ, Martin Leroy C, et al. Reduced exposure evaluation of an electrically heated cigarette smoking system. Part 4: Eight-day randomized clinical trial in Korea. Regul Toxicol Pharmacol 2012;64(Suppl):S45-53.
7. Tricker AR, Kanada S, Takada K, et al. Reduced exposure evaluation of an electrically heated cigarette smoking system. Part 5: 8-Day randomized clinical trial in Japan. Regul Toxicol Pharmacol 2012;64(Suppl):S54-63.
8. Tricker AR, Kanada S, Takada K, et al. Reduced exposure evaluation of an electrically heated cigarette smoking system. Part 6: 6-Day randomized clinical trial of a menthol cigarette in Japan. Regul Toxicol Pharmacol 2012;64(Suppl):S64-73.
9. Martin Leroy C, Jarus-Dziedzic K, Ancerewicz J, et al. Reduced exposure evaluation of an Electrically Heated Cigarette Smoking System. Part 7: A one-month, randomized, ambulatory, controlled clinical study in Poland. Regul Toxicol Pharmacol 2012;64(Suppl):S74-84.
10. Urban HJ, Tricker AR, Leyden DE, et al. Reduced exposure evaluation of an Electrically Heated Cigarette Smoking System. Part 8: Nicotine bridging- estimating smoke constituent exposure by their relationships to both nicotine levels in mainstream cigarette smoke and in smokers. Regul Toxicol Pharmacol 2012;64(Suppl):S85-97.
11. Smith MR, Clark B, Lüdicke F, et al. Evaluation of the Tobacco Heating System 2. 2. Part 1: Description of the system and the scientific assessment program. Regul Toxicol Pharmacol 2016;81(Suppl 2):S17-26.
12. Schaller JP, Keller D, Poget L, et al. Evaluation of the Tobacco Heating System 2. 2. Part 2: Chemical composition, genotoxicity, cytotoxicity, and physical properties of the aerosol. Regul Toxicol Pharmacol 2016;81(Suppl 2):S27-47.
13. Schaller JP, Pijnenburg JP, Ajithkumar A, et al. Evaluation of the Tobacco Heating System 2. 2. Part 3: Influence of the tobacco blend on the formation of harmful and potentially harmful constituents of the Tobacco Heating System 2. 2 aerosol. Regul Toxicol Pharmacol 2016;81(Suppl 2):S48-58.
14. Wong ET, Kogel U, Veljkovic E, et al. Evaluation of the Tobacco Heating System 2. 2. Part 4: 90-day OECD 413 rat inhalation study with systems toxicology endpoints demonstrates reduced exposure effects compared with cigarette smoke. Regul Toxicol Pharmacol 2016;81(Suppl 2):S59-81.
15. Sewer A, Kogel U, Talikka M, et al. Evaluation of the Tobacco Heating System 2. 2 (THS2. 2). Part 5: microRNA expression from a 90-day rat inhalation study indicates that exposure to THS2. 2 aerosol causes reduced effects on lung tissue compared with cigarette smoke. Regul Toxicol Pharmacol 2016;81(Suppl 2):S82-92.
16. Oviedo A, Lebrun S, Kogel U, et al. Evaluation of the Tobacco Heating System 2. 2. Part 6: 90-day OECD 413 rat inhalation study with systems toxicology endpoints demonstrates reduced exposure effects of a mentholated version compared with mentholated and non-mentholated cigarette smoke. Regul Toxicol Pharmacol 2016;81(Suppl 2):S93-122.
17. Kogel U, Titz B, Schlage WK, et al. Evaluation of the tobacco heating system 2. 2. Part 7: systems toxicological assessment of a mentholated version revealed reduced cellular and molecular exposure effects compared with mentholated and non-mentholated cigarette smoke. Regul Toxicol Pharmacol 2016;81(Suppl 2):S123-138.
18. Haziza C, de La Bourdonnaye G, Skiada D, et al. Evaluation of the tobacco heating system 2. 2. Part 8: 5-Day randomized reduced exposure clinical study in Poland. Regul Toxicol Pharmacol 2016;81(Suppl 2):S139-50.
19. Martin F, Talikka M, Ivanov NV, et al. Evaluation of the tobacco heating system 2. 2. Part 9: Application of systems pharmacology to identify exposure response markers in peripheral blood of smokers switching to THS2. 2. Regul Toxicol Pharmacol 2016;81(Suppl 2):S151-57.
20. van der Toorn M, Frentzel S, De Leon H, et al. Aerosol from a candidate modified risk tobacco product has reduced effects on chemotaxis and transendothelial migration compared to combustion of conventional cigarettes. Food Chem Toxicol 2015;86:81-7.
21. Poussin C, Laurent A, Peitsch MC, et al. Systems toxicology-based assessment of the candidate modified risk tobacco product THS2. 2 for the adhesion of monocytic cells to human coronary arterial endothelial cells. Toxicology 2016;339:73-86.
22. Lüdicke F, Picavet P, Baker G, et al. Effects of switching to the tobacco heating system 2. 2 menthol, smoking abstinence, or continued cigarette smoking on biomarkers of exposure: A randomized, controlled, open-label, multicenter study in sequential confinement and ambulatory settings (Part 1). Nicotine Tob Res 2018;20:161-72.
23. Lüdicke F, Picavet P, Baker G, et al. Effects of switching to the menthol tobacco heating system 2. 2, smoking abstinence, or continued cigarette smoking on clinically relevant risk markers: A randomized, controlled, open-label, multicenter study in sequential confinement and ambulatory settings (Part 2). Nicotine Tob Res 2018;20:173-82.
24. Pyke KE, Tschakovsky ME. The relationship between shear stress and flow-mediated dilatation: implications for the assessment of endothelial function. J Physiol 2005;568(Pt 2):357-69.
25. Flammer AJ, Anderson T, Celermajer DS, et al. The assessment of endothelial function: from research into clinical practice. Circulation 2012;126:753-67.
26. Celermajer DS, Sorensen KE, Gooch VM, et al. Non-invasive detection of endothelial dysfunction in children and adults at risk of atherosclerosis. Lancet 1992;340:1111-5.
27. Nabel EG, Selwyn AP, Ganz P. Large coronary arteries in humans are responsive to changing blood flow: An endothelium-dependent mechanism that fails in patients with atherosclerosis. J Am Coll Cardiol 1990;16:349-56.
28. Celermajer DS, Sorensen KE, Georgakopoulos D, et al. Cigarette smoking is associated with dose-related and potentially reversible impairment of endothelium-dependent dilation in healthy young adults. Circulation 1993;88(5 Pt 1):2149-55.
29. Celermajer DS, Adams MR, Clarkson P, et al. Passive smoking and impaired endothelium-dependent arterial dilatation in healthy young adults. N Engl J Med 1996;334:150-5.
30. Kato T, Inoue T, Morooka T, et al. Short-term passive smoking causes endothelial dysfunction via oxidative stress in nonsmokers. Can J Physiol Pharmacol 2006;84:523-9.
31. Heiss C, Amabile N, Lee AC, et al. Brief secondhand smoke exposure depresses endothelial progenitor cells activity and endothelial function: sustained vascular injury and blunted nitric oxide production. J Am Coll Cardiol 2008;51:1760-71.
32. Carnevale R, Sciarretta S, Violi F, et al. Acute impact of tobacco vs electronic cigarette smoking on oxidative stress and vascular function. Chest 2016;150:606-12.
33. Heiss C, Sievers RE, Amabile N, et al. In vivo measurement of flow-mediated vasodilation in living rats using high-resolution ultrasound. Am J Physiol Heart Circ Physiol 2008;294:H1086-93.
34. Pinnamaneni K, Sievers RE, Sharma R, et al. Brief exposure to secondhand smoke reversibly impairs endothelial vasodilatory function. Nicotine Tob Res 2014;16:584-90.
35. Liu J, Wang X, Narayan S, et al. Impairment of endothelial function by little cigar secondhand smoke. Tob Regul Sci 2016;2:56-63.
36. Wang X, Derakhshandeh R, Liu J, et al. One minute of marijuana secondhand smoke exposure substantially impairs vascular endothelial function. J Am Heart Assoc 2016;5:e003858.
37. Havel CM, Benowitz NL, Jacob P, et al. An electronic cigarette vaping machine for the characterization of aerosol delivery and composition. Nicotine Tob Res 2017;19:1224-31.
38. Jacob P, Yu L , Yu L, et al. Simultaneous determination of mecamylamine, nicotine, and cotinine in plasma by gas chromatography-mass spectrometry. J Pharm Biomed Anal 2000;23:653-61.
39. Russell MA, Feyerabend C, Cole PV. Plasma nicotine levels after cigarette smoking and chewing nicotine gum. Br Med J 1976;1:1043-6.
40. Benowitz NL, Jacob P. Daily intake of nicotine during cigarette smoking. Clin Pharmacol Ther 1984;35:499-504.
41. Caputi TL. Industry watch: heat-not-burn tobacco products are about to reach their boiling point. Tob Control 2016;26:609-10.
42. Dutra LM, Grana R, Glantz SA. Philip Morris research on precursors to the modern e-cigarette since 1990. Tob Control 2017;26 e97-e105.
43. Herzog B, Kanada P, Scott A. "Tobacco talk " - Q1 U. S. Retailer survey, 4/26/17. 2017.
44. Phillips B, Veljkovic E, Boué S, et al. An 8-month systems toxicology inhalation/ cessation study in apoe-/- mice to investigate cardiovascular and respiratory exposure effects of a candidate modified risk tobacco product, ths 2. 2, compared with conventional cigarettes. Toxicol Sci 2016;149:411-32.
45. Administration USFaD, Philip Morris Products S. A. Modified risk tobacco product (MRTP). https://www. fda. gov/ TobaccoProducts/ Labeling/ Mark etin gand Adve rtising/ ucm546281. htm.
46. Reznik GK. Comparative anatomy, physiology, and function of the upper respiratory tract. Environ Health Perspect 1990;85:171-6.
47. Lai YL, Hildebrandt J. Respiratory mechanics in the anesthetized rat. J Appl Physiol Respir Environ Exerc Physiol 1978;45:255-60.
48. Whitehead GS, Kimmel EC, Reboulet JE, et al. Pulmonary function in normal rats. Naval health research center detachment report No Toxdet 99-5. Bethesda, MD: Naval Medical Research and Development Command, 1999.
49. Kuempel ED, Sweeney LM, Morris JB, et al. Advances in inhalation dosimetry models and methods for occupational risk assessment and exposure limit derivation. J Occup Environ Hyg 2015;12(Suppl 1):S18-S40.
50. Bekki K, Inaba Y, Uchiyama S, et al. Comparison of chemicals in mainstream smoke in heat-not-burn tobacco and combustion cigarettes. J Uoeh 2017;39:201-7.
51. Auer R, Concha-Lozano N, Jacot-Sadowski I, et al. Heat-not-burn tobacco cigarettes: smoke by any other name. JAMA Intern Med 2017;177:1050-2.
52. Chen Q, Sievers RE, Varga M, et al. Pharmacological inhibition of S-nitrosoglutathione reductase improves endothelial vasodilatory function in rats in vivo. J Appl Physiol 2013;114:752-60.
53. Frey PF, Ganz P, Hsue PY, et al. The exposure-dependent effects of aged secondhand smoke on endothelial function. J Am Coll Cardiol 2012;59:1908-13.